about
Histamine: a novel approach to cancer immunotherapy.An overview of cancer immunotherapy.Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma.Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2.Histamine dihydrochloride and cancer.A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects.
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Histamine in cancer immunotherapy.
@en
type
label
Histamine in cancer immunotherapy.
@en
prefLabel
Histamine in cancer immunotherapy.
@en
P2093
P2860
P1476
Histamine in cancer immunotherapy.
@en
P2093
Carneskog J
Hellstrand K
Hermodsson S
Mellqvist UH
P2860
P304
P356
10.3109/00365519709060027
P577
1997-05-01T00:00:00Z